Integrating patient-reported outcomes into clinical practice guidelines for cardiometabolic conditions may enhance person-centered care and shared decision-making.
Recent clinical practice guidelines for diabetes, obesity, cardiovascular disease (CVD) and chronic kidney disease (CKD) emphasise a holistic, person-centred approach to care. However, they do not include recommendations for the assessment of patient-reported outcomes (PROs), which would – dependent on the topic of guideline – be important for improving shared decision-making, patients’ concordance with guideline recommendations, clinical outcomes and health-related quality of life (HRQoL). The Taskforce of the Guideline Workshop discussed PROs in diabetes, obesity, CVD and CKD as well as the relevance of their inclusion in clinical practice guidelines for the management of these conditions.
No takes yet. Share an insight, caveat, or question.
Barnard‐Kelly et al. (2025) conducted a review in Diabetes, obesity, cardiovascular disease, and chronic kidney disease. Patient-reported outcomes (PROs) assessment was evaluated. The Taskforce highlighted the importance of including patient-reported outcomes in clinical practice guidelines for diabetes, obesity, cardiovascular disease, and chronic kidney disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: